Bloomage BioTechnology Corporation Limited Stock

Equities

688363

CNE100003NL9

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-27 pm EDT 5-day change 1st Jan Change
58.64 CNY -2.10% Intraday chart for Bloomage BioTechnology Corporation Limited -6.82% -12.39%
Sales 2024 * 6.84B 944M Sales 2025 * 8.23B 1.14B Capitalization 28.07B 3.87B
Net income 2024 * 845M 117M Net income 2025 * 1.12B 155M EV / Sales 2024 * 3.92 x
Net cash position 2024 * 1.27B 175M Net cash position 2025 * 1.48B 205M EV / Sales 2025 * 3.23 x
P/E ratio 2024 *
33.4 x
P/E ratio 2025 *
25.1 x
Employees 4,655
Yield 2024 *
0.88%
Yield 2025 *
1.15%
Free-Float 29.33%
More Fundamentals * Assessed data
Dynamic Chart
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023. CI
Bloomage Biotech Names CFO MT
Bloomage Biotechnology's 2023 Profit Falls 39.5%; Misses EPS Estimates MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Bloomage Buys Back 8.4 Million Yuan Shares MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Bloomage BioTechnology Corporation Limited announces an Equity Buyback for CNY 300 million worth of its shares. CI
Bloomage BioTechnology Corporation Limited authorizes a Buyback Plan. CI
Chinese company earnings reveal lopsided economic recovery RE
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bloomage Biotech Showcases Cutting-Edge Bioactive Ingredients at International Consumer Products Expo, Expands Global Reach CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yongtaiyun Chemical Logistics to Buy Local Chemical Producer For 50 Million Yuan MT
More news
1 day-2.10%
1 week-6.82%
Current month-4.65%
1 month-2.14%
3 months-5.42%
6 months-21.08%
Current year-12.39%
More quotes
1 week
58.25
Extreme 58.25
71.77
1 month
58.25
Extreme 58.25
71.77
Current year
50.22
Extreme 50.22
71.77
1 year
50.22
Extreme 50.22
99.49
3 years
50.22
Extreme 50.22
314.99
5 years
50.22
Extreme 50.22
314.99
10 years
50.22
Extreme 50.22
314.99
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 02-12-31
Director of Finance/CFO 39 19-12-12
Chief Tech/Sci/R&D Officer 59 99-12-31
Members of the board TitleAgeSince
Director/Board Member 49 18-03-31
Corporate Officer/Principal 61 16-12-31
Chief Tech/Sci/R&D Officer 59 99-12-31
More insiders
Date Price Change Volume
24-05-27 58.64 -2.10% 2 137 749
24-05-27 59.9 +0.37% 1,840,519
24-05-24 59.68 -2.32% 2,617,665
24-05-23 61.1 -5.34% 4,931,855
24-05-22 64.55 +5.15% 8,213,585

End-of-day quote Shanghai S.E., May 27, 2024

More quotes
Bloomage Biotechnology Corp Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of hyaluronic acid and other bioactive products. The Company's products include raw material products, medical end products, functional skin care products and functional foods. The raw material products include a series of bioactive products with hyaluronic acid as the core, which are widely used in the fields of drugs, medical devices, cosmetics, functional food and general food. The medical end products are divided into medical beauty and medicine, including ophthalmic viscoelastics, medical lubricants, soft tissue fillers, medical skin protectors and others. The functional skin care products include lotion, cream, facial mask, hand mask and others. The functional foods include hyaluronic acid water, hyaluronic acid food and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
58.64 CNY
Average target price
72.07 CNY
Spread / Average Target
+22.90%
Consensus
  1. Stock Market
  2. Equities
  3. 688363 Stock